The company currently supplies one product to the US market that contributes low- single digit revenue to Jubilant Pharmova revenue
The company will address the observations within a stipulated timeline working with the regulators
This will be an added advantage for Supriya Lifescience Limited in the European market.
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
This new fund is amongst the largest for the sector in India
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans
The association has lined up a string of prominent speakers from the government and private sector. Seasoned veterans and industry bigwigs will grace the two-day event in Mumbai
Subscribe To Our Newsletter & Stay Updated
